Directorio de personas
Diego Arango Del Corro

Diego Arango Del Corro

Grado: Doctor/a


darango(ELIMINAR)@irblleida.cat

ResearcherID: http://www.researcherid.com/rid/M-5667-2016

Grupos

Publicaciones

  • Dopeso H; Rodrigues P; Bilic J; Bazzocco S; Cartón-García F; Macaya I; de Marcondes PG; Anguita E; Masanas M; Jiménez-Flores LM; Martínez-Barriocanal Á; Nieto R; Segura MF; Schwartz S; Mariadason JM; Arango D

    Mechanisms of inactivation of the tumour suppressor gene RHOA in colorectal cancer.

    BRITISH JOURNAL OF CANCER 118 106-116. .

    [doi:10.1038/bjc.2017.420]

  • Mateo-Lozano S; Bazzocco S; Rodrigues P; Mazzolini R; Andretta E; Dopeso H; Fernández Y; Del Llano E; Bilic J; Suárez-López L; Macaya I; Cartón-García F; Nieto R; Jimenez-Flores LM; de Marcondes PG; Nuñez Y; Afonso E; Cacci K; Hernández-Losa J; Landolfi S; Abasolo I; Ramón Y Cajal S; Mariadason JM; Schwartz S; Matsui T; Arango D

    Loss of the EPH receptor B6 contributes to colorectal cancer metastasis.

    SCIENTIFIC REPORTS 7 43702-43702. .

    [doi:10.1038/srep43702]

  • Andretta E; Cartón-García F; Martínez-Barriocanal Á; de Marcondes PG; Jimenez-Flores LM; Macaya I; Bazzocco S; Bilic J; Rodrigues P; Nieto R; Landolfi S; Ramon Y Cajal S; Schwartz S; Brown A; Dopeso H; Arango D

    Investigation of the role of tyrosine kinase receptor EPHA3 in colorectal cancer.

    SCIENTIFIC REPORTS 7 41576-41576. .

    [doi:10.1038/srep41576]

  • Tögel L; Nightingale R; Chueh AC; Jayachandran A; Tran H; Phesse T; Wu R; Sieber OM; Arango D; Dhillon AS; Dawson MA; Diez-Dacal B; Gahman TC; Filippakopoulos P; Shiau AK; Mariadason JM

    Dual Targeting of Bromodomain and Extraterminal Domain Proteins, and WNT or MAPK Signaling, Inhibits c-MYC Expression and Proliferation of Colorectal Cancer Cells.

    MOLECULAR CANCER THERAPEUTICS 15 1217-1226. .

    [doi:10.1158/1535-7163.MCT-15-0724]

  • Gener P; Rafael DF; Fernández Y; Ortega JS; Arango D; Abasolo I; Videira M; Schwartz S

    Cancer stem cells and personalized cancer nanomedicine.

    Nanomedicine 11 307-320. .

    [doi:10.2217/nnm.15.200]

  • Gener P; Gouveia LP; Sabat GR; de Sousa Rafael DF; Fort NB; Arranja A; Fernández Y; Prieto RM; Ortega JS; Arango D; Abasolo I; Videira M; Schwartz S

    Fluorescent CSC models evidence that targeted nanomedicines improve treatment sensitivity of breast and colon cancer stem cells.

    Nanomedicine-Nanotechnology Biology and Medicine 11 1883-1892. .

    [doi:10.1016/j.nano.2015.07.009]

  • Bazzocco S; Dopeso H; Carton-Garcia F; Macaya I; Andretta E; Chionh F; Rodrigues P; Garrido M; Alazzouzi H; Nieto R; Sanchez A; Schwartz S; Bilic J; Mariadason JM; Arango D

    Highly Expressed Genes in Rapidly Proliferating Tumor Cells as New Targets for Colorectal Cancer Treatment.

    CLINICAL CANCER RESEARCH 21 3695-3704. .

    [doi:10.1158/1078-0432.CCR-14-2457]

  • Cartón-García F; Overeem AW; Nieto R; Bazzocco S; Dopeso H; Macaya I; Bilic J; Landolfi S; Hernandez-Losa J; Schwartz S; Ramon y Cajal S; van Ijzendoorn SC; Arango D

    Myo5b knockout mice as a model of microvillus inclusion disease.

    SCIENTIFIC REPORTS 5 12312-12312. .

    [doi:10.1038/srep12312]

  • Shin J; Carr A; Corner GA; Tögel L; Dávalos-Salas M; Tran H; Chueh AC; Al-Obaidi S; Chionh F; Ahmed N; Buchanan DD; Young JP; Malo MS; Hodin RA; Arango D; Sieber OM; Augenlicht LH; Dhillon AS; Weber TK; Mariadason JM

    The intestinal epithelial cell differentiation marker intestinal alkaline phosphatase (ALPi) is selectively induced by histone deacetylase inhibitors (HDACi) in colon cancer cells in a Kruppel-like factor 5 (KLF5)-dependent manner.

    Journal Of Biological Chemistry 290 15392-15392. .

    [doi:10.1074/jbc.A114.557546]

  • Acun T; Demir K; Oztas E; Arango D; Yakicier MC

    PTPRD is homozygously deleted and epigenetically downregulated in human hepatocellular carcinomas.

    OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY 19 220-229. .

    [doi:10.1089/omi.2015.0010]

  • Rodrigues P; Macaya I; Bazzocco S; Mazzolini R; Andretta E; Dopeso H; Mateo-Lozano S; Bilic J; Cartón-García F; Nieto R; Suárez-López L; Afonso E; Landolfi S; Hernandez-Losa J; Kobayashi K; Ramón y Cajal S; Tabernero J; Tebbutt NC; Mariadason JM; Schwartz S; Arango D

    RHOA inactivation enhances Wnt signalling and promotes colorectal cancer.

    Nature Communications 5 5458-5458. .

    [doi:10.1038/ncomms6458]

  • Duarte S; Arango D; Parihar A; Hamel P; Yasmeen R; Doseff AI

    Apigenin protects endothelial cells from lipopolysaccharide (LPS)-induced inflammation by decreasing caspase-3 activation and modulating mitochondrial function.

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 14 17664-17679. .

    [doi:10.3390/ijms140917664]

Proyectos

  • Nueva aproximación terapéutica para el cáncer colorectal.
  • Antioxidant treatment as a novel therapeutic option for microvillus inclusion disease. ARMED
  • Programa d'Impuls al Talent i l'Ocupabilitat (2021-2024)
  • Nueva estrategia terapéutica para ael cáncer gástrico basada en la modulación de la señalización de RHOA
  • Desarrollo de nanosistemas de marcaje de CXCR4 mediante radiosondas para la imagen molecular de células tumorales y del microambiente tumoral
  • Identificación de nuevos biomarcadores de respuesta a los compuestos regorafenib y TAS-102 en pacientes con cáncer colorrectal.
  • Targeting tumor microevironment by a translational multivalent nanomedicine: towards an effective anticancer combination immunotherapy